An Influenza A/H1N1/2009 Hemagglutinin Vaccine Produced in Escherichia coli

Predicting the Antigenic Structure of the Pandemic (H1N1) 2009 Influenza Virus Hemagglutinin

(2010) Manabu Igarashi et al.   PLoS One

Specific Recognition of Influenza A/H1N1/2009 Antibodies in Human Serum: A Simple Virus-Free ELISA Method

(2010) Mario M. Alvarez et al.   PLoS One

Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus

(2010) R. Xu et al.   SCIENCE

Immunological study of HA1 domain of hemagglutinin of influenza H5N1 virus

(2009) Fang-Feng Chiu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Antigenicity of a Type A Influenza Virus Through Comparison of Hemagglutination Inhibition and Mass Spectrometry Immunoassays

(2009) Alexander B. Schwahn et al.   JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY

Safety and Immunogenicity of a Novel Influenza Subunit Vaccine Produced in Mammalian Cell Culture

(2009) Agnieszka Szymczakiewicz‐Multanowska et al.   JOURNAL OF INFECTIOUS DISEASES

A novel Ecotin-Ubiquitin-Tag (ECUT) for efficient, soluble peptide production in the periplasm of Escherichia coli

(2009) Michael Paal et al.   Microbial Cell Factories

Adaptive Vaccination Strategies to Mitigate Pandemic Influenza: Mexico as a Case Study

(2009) Gerardo Chowell et al.   PLoS One

Evaluation of the Efficacy and Cross-Protectivity of Recent Human and Swine Vaccines against the Pandemic (H1N1) 2009 Virus Infection

(2009) Philippe Noriel Q. Pascua et al.   PLoS One

Evolutionary Trends of A(H1N1) Influenza Virus Hemagglutinin Since 1918

(2009) Jun Shen et al.   PLoS One

Conversion of MDCK cell line to suspension culture by transfecting with human siat7e gene and its application for influenza virus production

(2009) C. Chu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Glycans on influenza hemagglutinin affect receptor binding and immune response

(2009) C.-C. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Transmissibility and Control of Pandemic Influenza A (H1N1) Virus

(2009) Y. Yang et al.   SCIENCE

Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus

(2009) Zuzana Biesova et al.   VACCINE

Use of MDCK cells for production of live attenuated influenza vaccine

(2009) Jonathan Liu et al.   VACCINE

Glycan analysis in cell culture-based influenza vaccine production: Influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin

(2009) Jana Schwarzer et al.   VACCINE

Cross-Protective Potential of a Novel Monoclonal Antibody Directed against Antigenic Site B of the Hemagglutinin of Influenza A Viruses

(2009) Reiko Yoshida et al.   PLoS Pathogens

NEW technologies for meeting the global demand for pandemic influenza vaccines

(2008) David S. Fedson   BIOLOGICALS

Comparing the antibody responses against recombinant hemagglutinin proteins of avian influenza A (H5N1) virus expressed in insect cells and bacteria

(2008) Shuo Shen et al.   JOURNAL OF MEDICAL VIROLOGY

Vaccination of BALB/c Mice with Escherichia coli-Expressed Vaccinia Virus Proteins A27L, B5R, and D8L Protects Mice from Lethal Vaccinia Virus Challenge

(2008) A. Berhanu et al.   JOURNAL OF VIROLOGY

Cross-Protection against Lethal H5N1 Challenge in Ferrets with an Adjuvanted Pandemic Influenza Vaccine

(2008) Benoît Baras et al.   PLoS One

Efficacious Recombinant Influenza Vaccines Produced by High Yield Bacterial Expression: A Solution to Global Pandemic and Seasonal Needs

(2008) Langzhou Song et al.   PLoS One